86 related articles for article (PubMed ID: 8147494)
21. Vaccination against lyme disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horses.
Chang Y; Novosol V; McDonough SP; Chang CF; Jacobson RH; Divers T; Quimby FW; Shin S; Lein DH
Vaccine; 1999 Oct; 18(5-6):540-8. PubMed ID: 10519945
[TBL] [Abstract][Full Text] [Related]
22. Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice.
Fikrig E; Telford SR; Barthold SW; Kantor FS; Spielman A; Flavell RA
Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5418-21. PubMed ID: 1608951
[TBL] [Abstract][Full Text] [Related]
23. Serologic surveillance for the Lyme disease spirochete, Borrelia burgdorferi, in Minnesota by using white-tailed deer as sentinel animals.
Gill JS; McLean RG; Shriner RB; Johnson RC
J Clin Microbiol; 1994 Feb; 32(2):444-51. PubMed ID: 8150955
[TBL] [Abstract][Full Text] [Related]
24. A murine IgG1 monoclonal antibody that binds specifically to outer surface protein A of Lyme disease spirochete Borrelia burgdorferi.
Abolhassani M; Pavia CS; Dunn JJ; Chiao JW
FEMS Microbiol Lett; 1993 May; 109(2-3):303-9. PubMed ID: 8339920
[TBL] [Abstract][Full Text] [Related]
25. Comparison in the immunological properties of Borrelia burgdorferi isolates from Ixodes ricinus derived from three endemic areas in Switzerland.
Hu CM; Leuba-Garcia S; Kramer MD; Aeschlimann A; Gern L
Epidemiol Infect; 1994 Jun; 112(3):533-42. PubMed ID: 8005219
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of Borrelia burgdorferi s.l. OspA types in Ixodes ricinus ticks from selected localities in Slovakia and Poland.
Lencáková D; Hizo-Teufel C; Petko B; Schulte-Spechtel U; Stanko M; Wilske B; Fingerle V
Int J Med Microbiol; 2006 May; 296 Suppl 40():108-18. PubMed ID: 16530478
[TBL] [Abstract][Full Text] [Related]
27. Human granulocytic ehrlichiosis agent infection in a pony vaccinated with a Borrelia burgdorferi recombinant OspA vaccine and challenged by exposure to naturally infected ticks.
Chang YF; McDonough SP; Chang CF; Shin KS; Yen W; Divers T
Clin Diagn Lab Immunol; 2000 Jan; 7(1):68-71. PubMed ID: 10618280
[TBL] [Abstract][Full Text] [Related]
28. T helper cell priming of mice to Borrelia burgdorferi OspA leads to induction of protective antibodies following experimental but not tick-borne infection.
Zhong W; Gern L; Kramer M; Wallich R; Simon MM
Eur J Immunol; 1997 Nov; 27(11):2942-7. PubMed ID: 9394822
[TBL] [Abstract][Full Text] [Related]
29. Natural antibody affects survival of the spirochete Borrelia burgdorferi within feeding ticks.
Belperron AA; Bockenstedt LK
Infect Immun; 2001 Oct; 69(10):6456-62. PubMed ID: 11553590
[TBL] [Abstract][Full Text] [Related]
30. Characterization of Borrelia burgdorferi sensu lato strains isolated from Ixodes ricinus in Mecklenburg-Vorpommern, Germany.
Lottmann H; Wilske B; Herrmann H
Med Microbiol Immunol; 1996 Feb; 184(4):181-4. PubMed ID: 8811650
[TBL] [Abstract][Full Text] [Related]
31. A fluorescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum.
Wagner B; Freer H; Rollins A; Erb HN
Vet Immunol Immunopathol; 2011 Apr; 140(3-4):190-8. PubMed ID: 21208663
[TBL] [Abstract][Full Text] [Related]
32. A relapsing fever group spirochete transmitted by Ixodes scapularis ticks.
Scoles GA; Papero M; Beati L; Fish D
Vector Borne Zoonotic Dis; 2001; 1(1):21-34. PubMed ID: 12653133
[TBL] [Abstract][Full Text] [Related]
33. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.
Scheckelhoff MR; Telford SR; Hu LT
Vaccine; 2006 Mar; 24(11):1949-57. PubMed ID: 16300863
[TBL] [Abstract][Full Text] [Related]
34. [Detection of the spirochete Borrelia burgdorferi in Ixodid ticks using solid-phase immunoenzyme analysis (ELISA)].
Burakova OV; Arumova EA; Dzhaĭkieva
Parazitologiia; 1997; 31(6):521-6. PubMed ID: 9541935
[TBL] [Abstract][Full Text] [Related]
35. Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host.
Das S; Barthold SW; Giles SS; Montgomery RR; Telford SR; Fikrig E
J Clin Invest; 1997 Mar; 99(5):987-95. PubMed ID: 9062357
[TBL] [Abstract][Full Text] [Related]
36. Vaccination against Lyme disease caused by diverse Borrelia burgdorferi.
Fikrig E; Telford SR; Wallich R; Chen M; Lobet Y; Matuschka FR; Kimsey RB; Kantor FS; Barthold SW; Spielman A; Flavell RA
J Exp Med; 1995 Jan; 181(1):215-21. PubMed ID: 7807004
[TBL] [Abstract][Full Text] [Related]
37. Purification of Borrelia burgdorferi outer surface protein A (OspA) and analysis of antibody binding domains.
Jiang W; Gorevic PD; Dattwyler RJ; Dunn JJ; Luft BJ
Clin Diagn Lab Immunol; 1994 Jul; 1(4):406-12. PubMed ID: 8556477
[TBL] [Abstract][Full Text] [Related]
38. A reverse transcriptase-polymerase chain reaction assay of Borrelia burgdorferi 16S rRNA for highly sensitive quantification of pathogen load in a vector.
Ornstein K; Barbour AG
Vector Borne Zoonotic Dis; 2006; 6(1):103-12. PubMed ID: 16584333
[TBL] [Abstract][Full Text] [Related]
39. Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis.
Fawcett PT; Rose CD; Budd SM; Gibney KM
Clin Diagn Lab Immunol; 2001 Jan; 8(1):79-84. PubMed ID: 11139199
[TBL] [Abstract][Full Text] [Related]
40. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.
Molloy PJ; Berardi VP; Persing DH; Sigal LH
Clin Infect Dis; 2000 Jul; 31(1):42-7. PubMed ID: 10913394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
